Published 28 July 2009, doi:10.1136/bmj.b3050
Cite this as: BMJ 2009;339:b3050

Letters

A/H1N1 flu

HPA advice on antipyretics contradicts NICE guideline

Julius Wagner-Jauregg won the Nobel prize in 1927 for developing an effective treatment for syphilis which entailed deliberately infecting patients with malaria. This research suggests that fever may be a beneficial response to infection. The 2007 guideline from the National Institute for Health and Clinical Excellence (NICE) on feverish illness in children under 5 reviewed the sparse evidence on using antipyretic medicines, which seems to indicate that artificially lowering a fever may reduce the immune response and prolong illness. NICE therefore recommended, "Do not routinely give antipyretic drugs to a child with fever with the sole aim of reducing body temperature."1

A small trial on the use of antipyretics in an intensive care unit was stopped because mortality was 16% in the treated group and 1% in the untreated group.2

The existing evidence suggests that antipyretics should be avoided in patients with pandemic flu,3 yet the Health Protection Agency (HPA) continues to recommend their routine use.4 We urgently need more research into the potential harmful effects of antipyretic medicines. When will the large scale randomised controlled trials be done?

Cite this as: BMJ 2009;339:b3050

Gina Johnson, general practitioner1

1 National Minor Illness Centre, Luton LU2 7HR

johgina{at}gmail.com


Competing interests: None declared.

References

  1. National Institute for Health and Clinical Excellence (NICE). Feverish illness in children. Assessment and initial management in children younger than 5 years. NICE guideline 47, 2007. www.nice.org.uk/nicemedia/pdf/CG47QuickRefGuide.pdf
  2. Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Alhaddad A, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surgical Infections 2005;6:369-75. doi: 10.1089/sur.2005.6.369[CrossRef][Medline]
  3. Hama R. NSAIDs and flu. BMJ 2009;338:b2345. (15 June.)[Free Full Text]
  4. Health Protection Agency. Summary of prescribing guidance for the treatment and prophylaxis of influenza-like illness: treatment phase, appendix five, version 1.5, 2009. www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1243581475043

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

HPA advice on antipyretics does not contradict NICE
Justin McCracken
BMJ 2009 339: b3501. [Extract] [Full Text]

NSAIDs and flu
Rokuro Hama
BMJ 2009 338: b2345. [Extract] [Full Text]

This article has been cited by other articles:

  • McCracken, J. (2009). HPA advice on antipyretics does not contradict NICE. BMJ 339: b3501-b3501 [Full text]  

Rapid Responses:

Read all Rapid Responses

Re: HPA advice on antipyretics contradicts NICE guideline
Justin McCracken
bmj.com, 25 Aug 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ